Rothschild Investment Corp Nu Cana PLC Transaction History

Rothschild Investment Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 22, 2020	SELL	$5.55 - $8.48 $141,663 - $216,452	-25,525 Closed	0 $0
Q3 2019 Oct 11, 2019	SELL	$6.95 - $10.71 $17,722 - $27,310	-2,550 Reduced 9.08%	25,525 $185,000
Q2 2019 Jul 11, 2019	BUY	$9.74 - $17.45 $152,528 - $273,267	15,660 Added 126.14%	28,075 $291,000
Q1 2019 Apr 18, 2019	BUY	$10.92 - $18.03 $135,571 - $223,842	12,415 New	12,415 $211,000
Q4 2018 Jan 28, 2019	SELL	$13.0 - $22.57 $119,015 - $206,628	-9,155 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$20.12 - $26.86 $184,198 - $245,903	9,155 New	9,155 $228,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $64.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment Corp with notifications on news.